Fourth COVID-19 booster supercharges antibody defense in older adults, study says
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
COVID vaccine booster increases antibody responses, is protective in rhesus macaques | National Institutes of Health (NIH)
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
COVID antibodies appear to wane rapidly, so prepare for booster shots, study suggests – The Vacaville Reporter
Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine | BMC Research Notes | Full Text
Are COVID-19 vaccine boosters needed? | Virology Blog
Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron
Antibody Response to Omicron BA.4–BA.5 Bivalent Booster | NEJM
Boosting immunity to COVID-19 vaccines | Nature Medicine
Prof. Akiko Iwasaki on X: "Why do we need a booster shots? This is because B cell responses induced by first dose only generates lower levels, lower affinity and short lived antibody
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 - ScienceDirect
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint | medRxiv
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical ...
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years - The Lancet Regional
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
JCI - Durability of immune responses to mRNA booster vaccination against COVID-19
